Lutetium Lu-177
- Generic Name
- Lutetium Lu-177
- Brand Names
- Lutathera, Lumark, EndolucinBeta, Lutetium (177Lu) chloride Billev (previously Illuzyce)
- Drug Type
- Small Molecule
- Chemical Formula
- Lu
- CAS Number
- 14265-75-9
- Unique Ingredient Identifier
- BRH40Y9V1Q
- Associated Conditions
- Neuroendocrine Tumors
- Associated Therapies
- -
Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
Not Applicable
Active, not recruiting
- Conditions
- Neuroendocrine Tumors
- Interventions
- First Posted Date
- 2016-04-19
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 195
- Registration Number
- NCT02743741
- Locations
- 🇨🇦
Sunnybrook Odette Cancer Center, Toronto, Ontario, Canada
🇨🇦Princess Margaret Cancer Centre, Toronto, Ontario, Canada
🇨🇦Juravinski Cancer Centre, Hamilton, Ontario, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath